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S i n c ef o o dc h a l l e n g ei st i m ec o n s u m i n ga n dn o ta l w a y s
without a risk for the patient, surrogate parameters have
been introduced. Among the best studied are case his-
tory, size of Skin Prick Test and the level of specific IgE
towards a food allergen. In the later case, decision
points (ie. the level of specific IgE above which there
would be a 95 % probability of the patient being chal-
lenge positive) have been introduced for various foods,
including, egg, milk, nuts and peanuts. Two major pro-
blems arise, however, from such an approach. Firstly,
the decision point may vary considerably between cen-
tres. This has been shown for hen’s egg, where different
centres have published decision points varying from
>0,35 to above 14 kIU/l. Secondly, in many cases, cross
reacting antibodies may limit the validity of the decision
point. An example is seen in peanut allergy, where a
level above 10 kIU/l is considered positive in most pub-
lished papers; but higher levels of peanut IgE are often
detected in pollen allergic patients with high levels of
IgE towards grass and birch. Most foods contain several
allergenic proteins, with varying clinical relevance. Pea-
nut contain several allergens, of which some are clini-
cally irrelevant but important due to cross reaction with
IgE against pollen whereas others, especially the protein
ara H2, are directly correlated the clinical disease. Com-
ponent resolved diagnostics (CRD) may thus present a
major step forward in the search for surrogate para-
meters. The ideal surrogate parameter should be able to
discriminate between positive and negative challenge
and also to correlate to disease severity and clinical sen-
sitivity (threshold). Threshold is an important parameter
to establish both in the single patient, facilitating tailor
made guidelines for the patient, and in the community.
Measurement of specific to CRD’sw o u l dh o p e f u l l y
result in a better correlation to threshold than conven-
tional techniques, but this idea remains yet to be pro-
ven. In the peanut example above, although a very nice
decision point for ara H2 was established, less convin-
cing correlations to clinical threshold in the patient
population was found.
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